Cholesterol Target Value Achievement and Lipid-
lowering Therapy in Patients with Stable or Acute
Coronary Heart Disease in Vietnam - Results from
the Dyslipidemia International Study II
Nguyen Lan Viet, Pham Nguyen Vinh, Vo Thanh Nhan, Do Quang Huan,
Pham Manh Hung, Dang Mai Tram, Baishali Ambegaonkar, Carl A Baxter,
Philippe Brudi, Martin Horack, Dominik Lautsch, Anselm Gitt.
13 September 2018
September 2018, 25:1
1.World Health Organization. Disease and injury country estimates 2008 [Accessed July 2017]. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/.
2.Nguyen HN, Fujiyoshi A, Abbott RD, Miura K. Epidemiology of cardiovascular risk factors in Asian
countries. Circ J 2013;77:2851-9.
3.Nguyen HL, Ha DA, Phan DT, et al. Sex differences in clinical characteristics, hospital management practices, and in-hospital outcomes in patients hospitalized in a Vietnamese hospital with a first acute myocardial infarction. PLoS One 2014;9:e95631.
4.Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 2003;32:563-72.
5.Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
6.Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016.
7.Gitt AK, Lautsch D, Ferrieres J, et al. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients. Atherosclerosis 2016;255:200-9.
8.Chiang CE, Ferrieres J, Gotcheva NN, et al. Suboptimal control of lipid levels: results from 29 countries participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). J Atheroscler Thromb 2015.
9.Park JE, Chiang CE, Munawar M, et al. Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey. Eur J Prev Cardiol 2012;19:781-94.
10.European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-818.
11.Weng TC, Yang YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic
equivalence of statins. J Clin Pharm Ther 2010;35:139-51.
12.Nguyen HL, Nguyen QN, Ha DA, Phan DT, Nguyen NH, Goldberg RJ. Prevalence of comorbidities and their impact on hospital management and shortterm outcomes in Vietnamese patients hospitalized with a first acute myocardial infarction. PLoS One 2014;9:e108998.
13.Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 2016;23:636-48.
14.Chan RH, Chan PH, Chan KK, et al. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipidlowering
treatment in a Hong Kong regional centre. Hong Kong Med J 2012;18:395-406.
15.Wang KF, Chang CC, Wang KL, et al. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey. J Chin Med Assoc 2014;77:61-7.
16.Sung J, Kim SH, Song HR, Chi MH, Park JE. Lipidlowering treatment practice patterns in korea:
comparison with the data obtained from the CEPHEUS Pan-Asian study. J Atheroscler Thromb 2014;21:1219-27.
17.Munawar M, Hartono B, Rifqi S. LDL Cholesterol Goal Attainment in Hypercholesterolemia: CEPHEUS Indonesian Survey. Acta Cardiol Sin 2013;29:71-81.
18.Nguyen T, Nguyen TH, Pham HT, et al. Physicians’ adherence to acute coronary syndrome prescribing guidelines in Vietnamese hospital practice: a crosssectional study. Trop Med Int Health 2015;20:627-37.
19.Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438-45.
20.Josan K, Majumdar SR, McAlister FA. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. CMAJ 2008;178:576-84.
21.Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372:2387-97.
22.Yu CC, Lai WT, Shih KC, et al. Efficacy, safety and tolerability of ongoing statin plus ezetimibe
versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an openlabel, randomized clinical trial. BMC Res Notes 2012;5:251.
23.Setia S, Fung SS, Waters DD. Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag 2015;11:303-10.
24.Hirsh BJ, Smilowitz NR, Rosenson RS, Fuster V, Sperling LS. Utilization of and adherence to guidelinerecommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement. J Am Coll Cardiol 2015;66:184-92.
25.Chan JC, Kong AP, Bao W, Fayyad R, Laskey R. Safety of atorvastatin in Asian patients within clinical trials. Cardiovasc Ther 2016;34:431-40.
26.Birmingham BK, Bujac SR, Elsby R, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States. Eur J Clin Pharmacol 2015;71:329-40.
27.Li YF, Feng QZ, Gao WQ, Zhang XJ, Huang Y, Chen YD. The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report. BMC Cardiovasc Disord 2015;15:6.
28.Truong QB et al. The 2015 National Heart Association guideline on Dyslipidemia Diagnosis and
Management. The Journal of Vietnamese Cardiology online: http://vnha.org.vn/cate.asp?cate_id=167, accessed on September 9, 2017